At Nexus Alliance Biopharmaceuticals, our team has championed innovative R&D efforts, paving the way for advancements in oncology, CNS, and rare diseases. With a robust background in clinical development and medical research, my focus is on steering projects from IND through NDA/BLA, ensuring excellence in safety and efficacy. As Chief Medical Officer, I've played a pivotal role in product launches and strategic mergers and acquisitions.
Collaboration with regulatory bodies like the US FDA, EMA, and PMDA has been integral to my leadership, contributing to our industry-leading pharmacovigilance and surveillance strategies. Harnessing my expertise in bioinformatics and GenAI, I've facilitated the seamless transition of multiple assets from pre-clinical to post-marketing phases. These efforts reflect my unwavering commitment to enhancing patient outcomes and propelling medical innovation.
